Related references
Note: Only part of the references are listed.Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation
M. E. Bernardo et al.
BONE MARROW TRANSPLANTATION (2011)
Ex vivo expansion of umbilical cord blood for transplantation
S. S. Tung et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2010)
Identification of growth and attachment factors for the serum-free isolation and expansion of human mesenchymal stromal cells
Sunghoon Jung et al.
CYTOTHERAPY (2010)
CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties
Selim Kuci et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
A novel serum-free medium for the expansion of human mesenchymal stem cells
Lucas G. Chase et al.
STEM CELL RESEARCH & THERAPY (2010)
Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability
Richard Schaefer et al.
CYTOTHERAPY (2009)
Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults
Rosa Gonzalo-Daganzo et al.
CYTOTHERAPY (2009)
Cotransplantation with MSCs improves engraftment of HSCs after autologous intra-bone marrow transplantation in nonhuman primates
Shigeo Masuda et al.
EXPERIMENTAL HEMATOLOGY (2009)
Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1
Venkata Lokesh Battula et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Cotransplantation of Placental Mesenchymal Stromal Cells Enhances Single and Double Cord Blood Engraftment in Nonobese Diabetic/Severe Combined Immune Deficient Mice
Smita D. Hiwase et al.
STEM CELLS (2009)
Heat Shock Protein-90 beta Is Expressed at the Surface of Multipotential Mesenchymal Precursor Cells: Generation of a Novel Monoclonal Antibody, STRO-4, With Specificity for Mesenchymal Precursor Cells From Human and Ovine Tissues
Stan Gronthos et al.
STEM CELLS AND DEVELOPMENT (2009)
Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses
Helen Karlsson et al.
BLOOD (2008)
The Use of Clinically Approved Small Particles of Iron Oxide (SPIO) for Labeling of Mesenchymal Stem Cells Aggravates Clinical Symptoms in Experimental Autoimmune Encephalomyelitis and Influences Their In Vivo Distribution
Richard Schaefer et al.
CELL TRANSPLANTATION (2008)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study
H. Ning et al.
LEUKEMIA (2008)
Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone
Robert Sackstein et al.
NATURE MEDICINE (2008)
Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients
Elisabetta Traggiai et al.
STEM CELLS (2008)
Hnmunomodulatory properties of mesenchymal stromal cells
Alma J. Nauta et al.
BLOOD (2007)
Cotransplantation of ex vivo-expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation
Lynne M. Ball et al.
BLOOD (2007)
Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells
Katharina Schallmoser et al.
TRANSFUSION (2007)
Mesenchymal stem cells: a new strategy for immunosuppression?
Antonio Uccelli et al.
TRENDS IN IMMUNOLOGY (2007)
Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: Further insights in the search for a fetal calf serum substitute
M. E. Bernardo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
SSEA-4 identifies mesenchymal stem cells from bone marrow
Eun J. Gang et al.
BLOOD (2007)
Nonhematopoietic/endothelial SSEA-1+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment
Fernando Anjos-Afonso et al.
BLOOD (2007)
Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting
Alma J. Nauta et al.
BLOOD (2006)
Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells
Alma J. Nauta et al.
JOURNAL OF IMMUNOLOGY (2006)
Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation
Sara Pozzi et al.
EXPERIMENTAL HEMATOLOGY (2006)
Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation
GM Spaggiari et al.
BLOOD (2006)
Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells
SN Robinson et al.
BONE MARROW TRANSPLANTATION (2006)
Human mesenchymal stem cells modulate B-cell functions
A Corcione et al.
BLOOD (2006)
Clarification of the nomenclature for MSC: The international society for cellular therapy position statement
EM Horwitz et al.
CYTOTHERAPY (2005)
Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applications
C Doucet et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
In vitro expansion of human mesenchymal stem cells: Choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability
A Shahdadfar et al.
STEM CELLS (2005)
Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells
XX Jiang et al.
BLOOD (2005)
Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation
K Rieger et al.
EXPERIMENTAL HEMATOLOGY (2005)
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients
HM Lazarus et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation
DW Kim et al.
BLOOD (2004)
A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow
RF Wynn et al.
BLOOD (2004)
Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy
JL Spees et al.
MOLECULAR THERAPY (2004)
Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals
F Djouad et al.
BLOOD (2003)
Identification of the haematopoietic stem cell niche and control of the niche size
JW Zhang et al.
NATURE (2003)
Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice
WA Noort et al.
EXPERIMENTAL HEMATOLOGY (2002)
Failure of adult marrow-derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation
N Awaya et al.
EXPERIMENTAL HEMATOLOGY (2002)
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
M Di Nicola et al.
BLOOD (2002)
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
A Bartholomew et al.
EXPERIMENTAL HEMATOLOGY (2002)
Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion
SM Devine et al.
EXPERIMENTAL HEMATOLOGY (2001)
The dynamic in vivo distribution of bone marrow-derived mesenchymal stent cells after infusion
JZ Gao et al.
CELLS TISSUES ORGANS (2001)
Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy
ON Koc et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
